NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Spyre’s SPY001 Delivers Strong Early Results in Ulcerative Colitis Trial – Shares Jump

Spyre drug SPY001 showed strong IBD results, improving symptoms and remission in trials, boosting shares and future outlook.

Spyre’s SPY001 Delivers Strong Early Results in Ulcerative Colitis Trial – Shares Jump
Credit: Spyre Therapeutics
Already have an account? Sign in.
04/13/2026 · 8:50 AM
SYRE
/ Read more

Feed↓

Liquidia Gets Bullish Signal from Hikma vs Amarin Ruling
06/04/2026 · 4:55 PM

Liquidia Gets Bullish Signal from Hikma vs Amarin Ruling

Raymond James reiterates Strong Buy rating and $68 target on Liquidia after the Supreme Court’s positive Hikma v. Amarin decision.

/ Subscriber only
Lululemon Beats Q1 Expectations But Warns of Tough Road Ahead
Featured/ 06/04/2026 · 4:29 PM

Lululemon Beats Q1 Expectations But Warns of Tough Road Ahead

Lululemon beat Q1 2026 expectations with $2.5B revenue but slashed full-year and Q2 guidance due to weak US demand.

/ Subscriber only
Enobosarm Grabs Novo Nordisk’s Attention: Veru’s Big Obesity Breakthrough
Featured/ 06/04/2026 · 1:15 PM

Enobosarm Grabs Novo Nordisk’s Attention: Veru’s Big Obesity Breakthrough

Veru partnered with Novo Nordisk to test enobosarm + Wegovy for fat loss while keeping muscle; stock surged.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2026
Email address Subscribe